Abstract:ObjectivesTo investigate whether machine learning, which is widely used in disease prediction and diagnosis based on demographic data and serological markers, can predict herpes occurrence in patients with systemic lupus erythematosus (SLE).MethodsA total of 286 SLE patients were included in this study, including 200 SLE patients without herpes and 86 SLE patients with herpes. SLE patients were randomly divided into a training group and a test group, and 18 demographic characteristics and serological indicator… Show more
“…Other outcomes for patients with SLE included reduced risk of breast cancer with the presence of prognostic genetic biomarkers (ie, IRF7, IFI35 and EIF2AK2 gene expression) identified with LASSO. 165 Models for the prediction of joint erosions LR model (AUC 0.806), 164 herpes infection (RF, AUC 0.942) 167 and hypothyroidism (RF, AUC 0.772) 166 have also been developed using clinical and serological data. Among the selected features for these models, autoantibodies were found to be important predictors, for example, anti-carbamylated protein and anti-citrullinated protein antibodies for joint erosion 164 and anti-dsDNA and anti-SSB/La for hypothyroidism.…”
Section: Key Sle Findings By ML Reportsmentioning
confidence: 99%
“…Among the selected features for these models, autoantibodies were found to be important predictors, for example, anti-carbamylated protein and anti-citrullinated protein antibodies for joint erosion 164 and anti-dsDNA and anti-SSB/La for hypothyroidism. 167 ML models showed promise in predicting the risk of hospitalisation and length of stay from EMR data (best performing models LSTM and XGBoost, AUC 0.88) 20 41 42 142 169 and associated healthcare costs from administrative databases. 17 142 …”
Artificial intelligence and machine learning applications are emerging as transformative technologies in medicine. With greater access to a diverse range of big datasets, researchers are turning to these powerful techniques for data analysis. Machine learning can reveal patterns and interactions between variables in large and complex datasets more accurately and efficiently than traditional statistical methods. Machine learning approaches open new possibilities for studying SLE, a multifactorial, highly heterogeneous and complex disease. Here, we discuss how machine learning methods are rapidly being integrated into the field of SLE research. Recent reports have focused on building prediction models and/or identifying novel biomarkers using both supervised and unsupervised techniques for understanding disease pathogenesis, early diagnosis and prognosis of disease. In this review, we will provide an overview of machine learning techniques to discuss current gaps, challenges and opportunities for SLE studies. External validation of most prediction models is still needed before clinical adoption. Utilisation of deep learning models, access to alternative sources of health data and increased awareness of the ethics, governance and regulations surrounding the use of artificial intelligence in medicine will help propel this exciting field forward.
“…Other outcomes for patients with SLE included reduced risk of breast cancer with the presence of prognostic genetic biomarkers (ie, IRF7, IFI35 and EIF2AK2 gene expression) identified with LASSO. 165 Models for the prediction of joint erosions LR model (AUC 0.806), 164 herpes infection (RF, AUC 0.942) 167 and hypothyroidism (RF, AUC 0.772) 166 have also been developed using clinical and serological data. Among the selected features for these models, autoantibodies were found to be important predictors, for example, anti-carbamylated protein and anti-citrullinated protein antibodies for joint erosion 164 and anti-dsDNA and anti-SSB/La for hypothyroidism.…”
Section: Key Sle Findings By ML Reportsmentioning
confidence: 99%
“…Among the selected features for these models, autoantibodies were found to be important predictors, for example, anti-carbamylated protein and anti-citrullinated protein antibodies for joint erosion 164 and anti-dsDNA and anti-SSB/La for hypothyroidism. 167 ML models showed promise in predicting the risk of hospitalisation and length of stay from EMR data (best performing models LSTM and XGBoost, AUC 0.88) 20 41 42 142 169 and associated healthcare costs from administrative databases. 17 142 …”
Artificial intelligence and machine learning applications are emerging as transformative technologies in medicine. With greater access to a diverse range of big datasets, researchers are turning to these powerful techniques for data analysis. Machine learning can reveal patterns and interactions between variables in large and complex datasets more accurately and efficiently than traditional statistical methods. Machine learning approaches open new possibilities for studying SLE, a multifactorial, highly heterogeneous and complex disease. Here, we discuss how machine learning methods are rapidly being integrated into the field of SLE research. Recent reports have focused on building prediction models and/or identifying novel biomarkers using both supervised and unsupervised techniques for understanding disease pathogenesis, early diagnosis and prognosis of disease. In this review, we will provide an overview of machine learning techniques to discuss current gaps, challenges and opportunities for SLE studies. External validation of most prediction models is still needed before clinical adoption. Utilisation of deep learning models, access to alternative sources of health data and increased awareness of the ethics, governance and regulations surrounding the use of artificial intelligence in medicine will help propel this exciting field forward.
“…7 Machine learning, a vital branch of AI, can handle large-scale data simultaneously and provide rapid prediction results with high accuracy and automation. [8][9][10] It integrates medical data electronically and can encapsulate higher-order non-linear interactions between predictors-which traditional modeling approaches like logistic regression models cannot handle. 11 These AI/ machine learning advantages have developed it into various software systems applied in various life sciences.…”
Section: Introductionmentioning
confidence: 99%
“…It uses computer systems to implement prediction or decision‐making tasks using algorithms and statistical models 7 . Machine learning, a vital branch of AI, can handle large‐scale data simultaneously and provide rapid prediction results with high accuracy and automation 8–10 . It integrates medical data electronically and can encapsulate higher‐order non‐linear interactions between predictors—which traditional modeling approaches like logistic regression models cannot handle 11 .…”
ObjectiveThis study aims to construct an artificial intelligence (AI) model capable of effectively discriminating between abdominal Henoch‐Schönlein purpura (AHSP) and acute appendicitis (AA) in pediatric patients.MethodsA total of 6965 participants, comprising 2201 individuals with AHSP and 4764 patients with AA, were enrolled in the study. Additionally, 53 laboratory indicators were taken into consideration. Five distinct artificial intelligence (AI) models were developed employing machine learning algorithms, namely XGBoost, AdaBoost, Gaussian Naïve Bayes (GNB), MLPClassifier (MLP), and support vector machine (SVM). The performance of these prediction models was assessed through receiver operating characteristic (ROC) curve analysis, calibration curve assessment, and decision curve analysis (DCA).ResultsWe identified 32 discriminative indicators (p < .05) between AHSP and AA. Five indicators, namely the lymphocyte ratio (LYMPH ratio), eosinophil ratio (EO ratio), eosinophil count (EO count), neutrophil ratio (NEUT ratio), and C‐reactive protein (CRP), exhibited strong performance in distinguishing AHSP from AA (AUC ≥ 0.80). Among the various prediction models, the XGBoost model displayed superior performance evidenced by the highest AUC (XGBoost = 0.895, other models < 0.89), accuracy (XGBoost = 0.824, other models < 0.81), and Kappa value (XGBoost = 0.621, other models < 0.60) in the validation set. After optimization, the XGBoost model demonstrated remarkable diagnostic performance for AHSP and AA (AUC > 0.95). Both the calibration curve and decision curve analysis suggested the promising clinical utility and net benefits of the XGBoost model.ConclusionThe AI‐based machine learning model exhibits high prediction accuracy and can differentiate AHSP and AA from a data‐driven perspective.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.